Evrofarma SA

Athens Stock Exchange EVROF.AT

Evrofarma SA Shareholders' Equity for the year ending December 31, 2023: USD 17.91 M

Evrofarma SA Shareholders' Equity is USD 17.91 M for the year ending December 31, 2023, a 19.34% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Evrofarma SA Shareholders' Equity for the year ending December 31, 2022 was USD 15.01 M, a 4.59% change year over year.
Evrofarma SA Shareholders' Equity for the year ending December 31, 2021 was USD 14.35 M, a -9.30% change year over year.
Evrofarma SA Shareholders' Equity for the year ending December 31, 2020 was USD 15.82 M, a 18.76% change year over year.
Evrofarma SA Shareholders' Equity for the year ending December 31, 2019 was USD 13.32 M, a -0.13% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Athens Stock Exchange: EVROF.AT

Evrofarma SA

CEO	Mr. Paschalis H. Papazilakis
IPO Date	June 13, 2000
Location	Greece
Headquarters	1st km Didymoteicho – Orestiada
Employees	166
Sector	Consumers Staples
Industries Dairy & Milk

Description

Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, cheese, and fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.

Key trends

Past 5 years